Working… Menu

High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02960607
Recruitment Status : Unknown
Verified November 2016 by Yutao Liu, Chinese Academy of Medical Sciences.
Recruitment status was:  Recruiting
First Posted : November 9, 2016
Last Update Posted : November 18, 2016
Information provided by (Responsible Party):
Yutao Liu, Chinese Academy of Medical Sciences

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 2018
Study Completion Date : No date given